glp-1 medication competitors pharmaceutical companies Antagonists Increase Plan Drug Spend - What's Next GLP-1 Agonists Market Report 2025-2033,

Higher doses can cause loose stool and gut cramps

Neurosci Lett 441:2528

Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans

Conversely, USPSTF reports that there is insufficient evidence to recommend thyroid dysfunction screening in non-pregnant or asymptomatic adults in 2015 [39]

Neal Fischbach: writing original draft (equal), writing review and editing (equal)

Though only currently indicated for diabetes, the combined HbA1c and weight loss benefits make Mounjaro a standout in the class, creating a level of demand that has significantly grown the size of the overall GLP-1 market